BusinessCURE Pharmaceutical and CannaKids Announce Research Collaboration with Technion-Israel Institute of Technology on Cancer-Fighting CannabinoidsBy Nasdaq OMXMay 31, 2017, 1:04 PM UTC
BusinessCURE Pharmaceutical and CannaKids Announce Research Collaboration with Technion-Israel Institute of Technology on Cancer-Fighting CannabinoidsBy Nasdaq OMXMay 31, 2017, 1:04 PM UTC
BusinessCURE Pharmaceutical and CannaKids Announce Research Collaboration with Technion-Israel Institute of Technology on Cancer-Fighting CannabinoidsBy Nasdaq OMXMay 31, 2017, 1:04 PM UTC
BusinessProLynx issued US patent for cleavable linker technology on hydrogelsBy Nasdaq OMXMay 31, 2017, 12:03 AM UTC
BusinessCURE Pharmaceutical Receives First Purchase Order Stemming from Product Development and License Agreement with Pharmaceutical Company, Meroven LTD.By Nasdaq OMXMay 24, 2017, 1:12 PM UTC
BusinessCURE Pharmaceutical Receives First Purchase Order Stemming from Product Development and License Agreement with Pharmaceutical Company, Meroven LTD.By Nasdaq OMXMay 24, 2017, 1:11 PM UTC
BusinessCURE Pharmaceutical Receives First Purchase Order Stemming from Product Development and License Agreement with Pharmaceutical Company, Meroven LTD.By Nasdaq OMXMay 24, 2017, 1:11 PM UTC
BusinessCURE Pharmaceutical Receives First Purchase Order Stemming from Product Development and License Agreement with Pharmaceutical Company, Meroven LTD.By Nasdaq OMXMay 24, 2017, 1:11 PM UTC
